Extending the Time for Thrombolysis in Emergency Neurological Deficits
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT00887328
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT00887328
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Finland, New Zealand
- Registry status
- Completed
Technical summary
Registry record NCT00887328. Randomized; triple masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2018-08-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Extending the Time for Thrombolysis in Emergency Neurological Deficits
- Acronym
- EXTEND
- Condition
- Stroke
- Intervention (Drug)
- Tissue Plasminogen Activator (Alteplase)
- Intervention (Drug)
- Placebo
- Lead sponsor
- Neuroscience Trials Australia
- Collaborator
- Commonwealth Scientific and Industrial Research Organisation, Australia
- Collaborator
- University of Melbourne
- Collaborator
- Melbourne Health
- Collaborator
- The Florey Institute of Neuroscience and Mental Health
Record details
- Record id
cardio:ct-nct00887328- Content hash
4d55106d40bbf8653562600f37e1b1e191e443687f98e40596f3791a150c19b0